MAC-AMP: A Closed-Loop Multi-Agent Collaboration System for Multi-Objective Antimicrobial Peptide Design

• URL: http://arxiv.org/abs/2602.14926v1
• Date: Mon, 16 Feb 2026 17:01:47 GMT
• Title: MAC-AMP: A Closed-Loop Multi-Agent Collaboration System for Multi-Objective Antimicrobial Peptide Design
• Authors: Gen Zhou, Sugitha Janarthanan, Lianghong Chen, Pingzhao Hu,
• Abstract summary: antimicrobial peptides (AMP) are being explored for their potent and promising ability to fight resistant pathogens.<n>Most AMP design models struggle to balance key goals like activity, toxicity, and novelty.<n>We introduce MAC-AMP, a closed-loop multi-agent collaboration system for multi-objective AMP design.
• Score: 2.624902795082451
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: To address the global health threat of antimicrobial resistance, antimicrobial peptides (AMP) are being explored for their potent and promising ability to fight resistant pathogens. While artificial intelligence (AI) is being employed to advance AMP discovery and design, most AMP design models struggle to balance key goals like activity, toxicity, and novelty, using rigid or unclear scoring methods that make results hard to interpret and optimize. As the capabilities of Large Language Models (LLM) advance and evolve swiftly, we turn to AI multi-agent collaboration based on such models (multi-agent LLMs), which show rapidly rising potential in complex scientific design scenarios. Based on this, we introduce MAC-AMP, a closed-loop multi-agent collaboration (MAC) system for multi-objective AMP design. The system implements a fully autonomous simulated peer review-adaptive reinforcement learning framework that requires only a task description and example dataset to design novel AMPs. The novelty of our work lies in introducing a closed-loop multi-agent system for AMP design, with cross-domain transferability, that supports multi-objective optimization while remaining explainable rather than a 'black box'. Experiments show that MAC-AMP outperforms other AMP generative models by effectively optimizing AMP generation for multiple key molecular properties, demonstrating exceptional results in antibacterial activity, AMP likeliness, toxicity compliance, and structural reliability.

Related papers

• MedSAM-Agent: Empowering Interactive Medical Image Segmentation with Multi-turn Agentic Reinforcement Learning [53.37068897861388]
  MedSAM-Agent is a framework that reformulates interactive segmentation as a multi-step autonomous decision-making process.<n>We develop a two-stage training pipeline that integrates multi-turn, end-to-end outcome verification.<n>Experiments across 6 medical modalities and 21 datasets demonstrate that MedSAM-Agent achieves state-of-the-art performance.
  arXiv  Detail & Related papers  (2026-02-03T09:47:49Z)
• ComAgent: Multi-LLM based Agentic AI Empowered Intelligent Wireless Networks [62.031889234230725]
  6G networks rely on complex cross-layer optimization.<n> manually translating high-level intents into mathematical formulations remains a bottleneck.<n>We present ComAgent, a multi-LLM agentic AI framework.
  arXiv  Detail & Related papers  (2026-01-27T13:43:59Z)
• Sample-Efficient Online Learning in LM Agents via Hindsight Trajectory Rewriting [92.57796055887995]
  We introduce ECHO, a prompting framework that adapts hindsight experience replay from reinforcement learning for language model agents.<n> ECHO generates optimized trajectories for alternative goals that could have been achieved during failed attempts.<n>We evaluate ECHO on stateful versions of XMiniGrid, a text-based navigation and planning benchmark, and PeopleJoinQA, a collaborative information-gathering enterprise simulation.
  arXiv  Detail & Related papers  (2025-10-11T18:11:09Z)
• OmegAMP: Targeted AMP Discovery through Biologically Informed Generation [37.08970479806285]
  Deep learning-based antimicrobial peptide (AMP) discovery faces critical challenges such as limited controllability.<n>We introduce OmegAMP, a framework designed for reliable AMP generation with increased controllability.<n>Our in silico experiments demonstrate that OmegAMP delivers state-of-the-art performance across key stages of the AMP discovery pipeline.
  arXiv  Detail & Related papers  (2025-04-24T04:53:04Z)
• MoFormer: Multi-objective Antimicrobial Peptide Generation Based on Conditional Transformer Joint Multi-modal Fusion Descriptor [15.98003148948758]
  We establish a multi-objective AMP synthesis pipeline (MoFormer) for the simultaneous optimization of multi-attributes of AMPs. MoFormer improves the desired attributes of AMP sequences in a highly structured latent space, guided by conditional constraints and fine-grained multi-descriptor. We show that MoFormer outperforms existing methods in the generation task of enhanced antimicrobial activity and minimal hemolysis.
  arXiv  Detail & Related papers  (2024-06-03T07:17:18Z)
• HMAMP: Hypervolume-Driven Multi-Objective Antimicrobial Peptides Design [11.891046340221735]
  This paper introduces a paradigm shift by considering multiple attributes in Antimicrobial peptides (AMPs) design. By synergizing reinforcement learning and a descent algorithm rooted in the hypervolume of AMP concept, HMAMP effectively expands exploration space and mitigates the issue of pattern collapse. A detailed analysis of the helical structures and molecular dynamics simulations for ten potential candidate AMPs validates the superiority of HMAMP in the realm of multi-objective AMP design.
  arXiv  Detail & Related papers  (2024-05-01T07:17:59Z)
• Accelerating Antimicrobial Peptide Discovery with Latent Structure [33.288514128470425]
  We propose a latent sequence-structure model for designing AMPs (LSSAMP) LSSAMP exploits multi-scale vector quantization in the latent space to represent secondary structures. Experimental results show that the peptides generated by LSSAMP have a high probability of antimicrobial activity.
  arXiv  Detail & Related papers  (2022-11-28T06:43:32Z)
• Graph-Based Active Machine Learning Method for Diverse and Novel Antimicrobial Peptides Generation and Selection [57.131117785001194]
  Large-scale screening of new AMP candidates is expensive, time-consuming, and now affordable in developing countries. We propose a novel active machine learning-based framework that statistically minimizes the number of wet-lab experiments needed to design new AMPs.
  arXiv  Detail & Related papers  (2022-09-18T14:30:48Z)
• Differentiable Agent-based Epidemiology [71.81552021144589]
  We introduce GradABM: a scalable, differentiable design for agent-based modeling that is amenable to gradient-based learning with automatic differentiation. GradABM can quickly simulate million-size populations in few seconds on commodity hardware, integrate with deep neural networks and ingest heterogeneous data sources.
  arXiv  Detail & Related papers  (2022-07-20T07:32:02Z)
• HMD-AMP: Protein Language-Powered Hierarchical Multi-label Deep Forest for Annotating Antimicrobial Peptides [5.61222966894307]
  We build a diverse and comprehensive multi-label protein sequence database by collecting and cleaning amino acids from various AMP databases. We develop an end-to-end hierarchical multi-label deep forest framework, HMD-AMP, to annotate AMP comprehensively. After identifying an AMP, it further predicts what targets the AMP can effectively kill from eleven available classes.
  arXiv  Detail & Related papers  (2021-11-11T02:10:07Z)
• Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics [109.70543391923344]
  CLaSS (Controlled Latent attribute Space Sampling) is an efficient computational method for attribute-controlled generation of molecules. We screen the generated molecules for additional key attributes by using deep learning classifiers in conjunction with novel features derived from atomistic simulations. The proposed approach is demonstrated for designing non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency.
  arXiv  Detail & Related papers  (2020-05-22T15:57:58Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.